Antitrust Lawsuit Targets 20 Generic Drug Manufacturers, 15 Industry Executives Over Medication Pricing – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889
Twenty large generic drug companies, and 15 individuals are facing a lawsuit from a 44-state coalition led by the Attorney General of Connecticut, William Tong, for allegedly conspiring to inflate prices, reduce competition, and restrain trade for over 100 generic drugs. Some of the drug prices were artificially inflated as much as 1000%, according to the antitrust lawsuit.
The generic drugs involved accounted for billions in sales in the United States, with price increases affecting the health insurance market, taxpayer-funded health care programs, and patients who need prescription drugs.